AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $12,044 | $17,986 | $20,509 | $10,845 |
| % Growth | -33% | -12.3% | 89.1% | – |
| Cost of Goods Sold | $3,708 | $5,732 | $7,628 | $6,047 |
| Gross Profit | $8,336 | $12,254 | $12,881 | $4,798 |
| % Margin | 69.2% | 68.1% | 62.8% | 44.2% |
| R&D Expenses | $9,532 | $16,204 | $11,576 | $9,839 |
| G&A Expenses | $70,788 | $80,676 | $74,757 | $70,781 |
| SG&A Expenses | $82,942 | $102,096 | $94,431 | $84,414 |
| Sales & Mktg Exp. | $12,154 | $21,420 | $19,674 | $13,633 |
| Other Operating Expenses | $0 | $0 | $0 | -$373 |
| Operating Expenses | $92,474 | $118,300 | $106,007 | $93,880 |
| Operating Income | -$84,138 | -$106,046 | -$93,126 | -$89,082 |
| % Margin | -698.6% | -589.6% | -454.1% | -821.4% |
| Other Income/Exp. Net | -$21,590 | -$9,170 | $13,903 | -$12,757 |
| Pre-Tax Income | -$105,728 | -$121,267 | -$80,653 | -$101,839 |
| Tax Expense | -$2,130 | -$1,180 | -$88 | -$218 |
| Net Income | -$103,598 | -$120,087 | -$80,565 | -$101,621 |
| % Margin | -860.2% | -667.7% | -392.8% | -937% |
| EPS | -54.18 | -176.53 | -143.99 | -205.96 |
| % Growth | 69.3% | -22.6% | 30.1% | – |
| EPS Diluted | -54.18 | -176.53 | -143.99 | -205.96 |
| Weighted Avg Shares Out | 1,912 | 680 | 560 | 493 |
| Weighted Avg Shares Out Dil | 1,912 | 680 | 560 | 493 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $373 | $4,257 | $1,143 | $2,609 |
| Depreciation & Amortization | $5,737 | -$4,041 | $15,713 | -$4,265 |
| EBITDA | -$99,618 | -$112,097 | -$77,413 | -$93,347 |
| % Margin | -827.1% | -623.2% | -377.5% | -860.7% |